WebAug 17, 2024 · August 17, 2024. On July 20, 2024, Biogen, Inc. (“Biogen” or the “Company”), formerly known as Biogen Idec, Inc., agreed to pay $900 million to resolve allegations that the Company violated the federal Anti-Kickback Statute (“AKS”) and False Claims Act (“FCA”) by paying physicians to prescribe its Multiple Sclerosis (“MS ... WebSep 26, 2024 · By Nate Raymond. BOSTON, Sept 26 (Reuters) - Biogen Inc has finalized a $900 million settlement resolving a whistleblower lawsuit accusing the biotech …
Biogen agrees to $900 million drug kickback settlement on eve of …
WebSep 26, 2024 · Biogen Inc has finalized a $900 million settlement resolving a whistleblower lawsuit accusing the biotech company of paying doctors kickbacks to prescribe multiple sclerosis drugs, the U.S ... WebSep 27, 2024 · A A. Biogen Inc. has finalized a $900 million settlement resolving a whistleblower lawsuit accusing the biotech company of paying doctors kickbacks to prescribe multiple sclerosis drugs, the U.S. Department of Justice said late Monday. The settlement resolves a long-running whistleblower lawsuit in Boston federal court that a … millies knoxville
Biogen Whistleblower Lawsuit Ends In Huge Settlement
WebConditioned upon the United States receiving the Settlement Amount from Biogen and as soon as feasible after receipt, the United States shall pay $3,960,000 to Relator by electronic funds transfer. 3. Subject to the exceptions in Paragraph 6 (concerning excluded claims) below, and WebJul 20, 2024 · The settlement ends a long-running battle that began in 2012, when a former Biogen sales manager named Michael Bawduniak filed a whistleblower lawsuit claiming the company ran thousands of speaker ... WebFeb 7, 2024 · In a case pursued by a whistleblower, the pharmaceutical company Biogen Inc. paid $843.8 million to resolve allegations that the company offered and paid kickbacks, including in the form of speaker honoraria, speaker training fees, consulting fees, and meals, to physicians who spoke at or attended Biogen programs in connection with Biogen’s ... millies lionheart